News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
09 Sep 2022
byNatalia Reoutova
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.
09 Sep 2022








